Goldman Sachs’s ClearPoint Neuro CLPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.42M | Buy |
286,792
+28,921
| +11% | +$345K | ﹤0.01% | 3077 |
|
|
2025
Q1 | $3.07M | Buy |
257,871
+127,823
| +98% | +$1.52M | ﹤0.01% | 3087 |
|
|
2024
Q4 | $2M | Buy |
130,048
+100,898
| +346% | +$1.55M | ﹤0.01% | 3478 |
|
|
2024
Q3 | $327K | Sell |
29,150
-97,434
| -77% | -$1.09M | ﹤0.01% | 4310 |
|
|
2024
Q2 | $682K | Buy |
126,584
+80,297
| +173% | +$433K | ﹤0.01% | 3793 |
|
|
2024
Q1 | $315K | Sell |
46,287
-277
| -0.6% | -$1.88K | ﹤0.01% | 4177 |
|
|
2023
Q4 | $316K | Sell |
46,564
-718
| -2% | -$4.88K | ﹤0.01% | 4157 |
|
|
2023
Q3 | $237K | Buy |
+47,282
| New | +$237K | ﹤0.01% | 4195 |
|
|
2023
Q2 | – | Sell |
-102,838
| Closed | -$868K | – | 4965 |
|
|
2023
Q1 | $868K | Buy |
102,838
+59,953
| +140% | +$506K | ﹤0.01% | 3757 |
|
|
2022
Q4 | $363K | Buy |
42,885
+7,206
| +20% | +$61K | ﹤0.01% | 4255 |
|
|
2022
Q3 | $370K | Sell |
35,679
-9,237
| -21% | -$95.8K | ﹤0.01% | 4427 |
|
|
2022
Q2 | $586K | Sell |
44,916
-10,752
| -19% | -$140K | ﹤0.01% | 4279 |
|
|
2022
Q1 | $580K | Buy |
55,668
+13,870
| +33% | +$145K | ﹤0.01% | 4474 |
|
|
2021
Q4 | $469K | Sell |
41,798
-68,963
| -62% | -$774K | ﹤0.01% | 4563 |
|
|
2021
Q3 | $1.97M | Buy |
110,761
+64,711
| +141% | +$1.15M | ﹤0.01% | 3500 |
|
|
2021
Q2 | $879K | Buy |
46,050
+21,018
| +84% | +$401K | ﹤0.01% | 4103 |
|
|
2021
Q1 | $529K | Buy |
+25,032
| New | +$529K | ﹤0.01% | 4315 |
|
|
2019
Q4 | – | Sell |
-33,206
| Closed | -$168K | – | 4288 |
|
|
2019
Q3 | $168K | Buy |
+33,206
| New | +$168K | ﹤0.01% | 3952 |
|